Lantheus
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Lantheus and other ETFs, options, and stocks.About LNTH
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease.
CEOBrian A. Markison
CEOBrian A. Markison
Employees808
Employees808
HeadquartersBedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded1956
Founded1956
Employees808
Employees808
LNTH Key Statistics
Market cap3.71B
Market cap3.71B
Price-Earnings ratio14.50
Price-Earnings ratio14.50
Dividend yield—
Dividend yield—
Average volume1.56M
Average volume1.56M
High today$54.70
High today$54.70
Low today$53.13
Low today$53.13
Open price$53.50
Open price$53.50
Volume2.23M
Volume2.23M
52 Week high$118.21
52 Week high$118.21
52 Week low$47.25
52 Week low$47.25
LNTH News
Simply Wall St 2d
Class Action Lawsuits Over Pylarify Disclosures Could Be a Game Changer for Lantheus HoldingsIn recent weeks, multiple law firms have announced class action lawsuits against Lantheus Holdings, alleging the company made false or misleading statements abo...
Simply Wall St 3d
Lantheus Holdings Valuation in Focus as Lawsuits and Analyst Downgrades Drive Market VolatilityIn the wake of multiple securities class action lawsuits, Lantheus Holdings (LNTH) has been navigating heightened market scrutiny. The legal challenges, rooted...
TipRanks 6d
Lantheus Downgraded to Neutral Amid Pricing Pressures and Acquisition UncertaintyGoldman Sachs analyst Paul Choi downgraded the rating on Lantheus to a Hold today, setting a price target of $77.00. Elevate Your Investing Strategy: Take advan...
Analyst ratings
77%
of 13 ratingsBuy
76.9%
Hold
23.1%
Sell
0%
People also own
Based on the portfolios of people who own LNTH. This list is generated using Robinhood data, and it’s not a recommendation.